Your search terms:
Facebook antitrust
Search results sorted by date
Tech
EU Parliament Adopts Ground-Breaking Digital Regulations Aimed at Big Tech
This week, the European Parliament greenlighted two laws aimed at reigning in certain big tech business practices and cementing user rights. According to a...
Tech
Meta Seeks Dismissal of Defunct Rival PHHHOTO’s Antitrust Suit
Meta Platforms Inc., owner of the social media platform Instagram, told a Brooklyn, New York judge to reject PHHHOTO Inc.’s monopolization and unfair business...
Tech
Briefing Concludes in State AGs’ Antitrust Appeal Against Facebook
A 52-page reply filed by the attorneys general of almost all 50 states pressed the D.C. Circuit to let their antitrust case against Facebook...
Tech
Advertiser Plaintiffs Oppose Dismissal of Amended Complaint in Facebook Antitrust Suit
A putative class of businesses who purchased advertisements from defendant Meta Platforms Inc. says that the allegations in its recently-filed first amended complaint leave...
Tech
Amici Throw Weight Behind Facebook in State AGs’ Antitrust Appeal
On Monday, several amici curiae pledged their support for Facebook’s cause in the antitrust case filed by nearly all state attorneys general in 2020....
Tech
Google Opposes Discovery Sanctions in DOJ’s Monopoly “Gate-Keeper” Suit
Late last week, Google LLC said that the federal government’s charge that it unfairly kept back evidence in the antitrust case proceeding in the...
Tech
Facebook Questions Advertisers’ Antitrust Claims in Second MTD; JPML Consolidates Case with Google Advertising Antitrust MDL
After a San Jose, California court refused to dismiss antitrust allegations against Facebook in January, the company has fired back at the advertiser plaintiffs’...
Tech
Facebook Files Opposition Brief in State AGs’ Antitrust Appeal Before D.C. Circuit
On Monday, Facebook, now Meta Platforms Inc., argued that a case brought by state attorneys general was correctly dismissed by Judge James E. Boasberg...
- Advertisement -
Latest news
Latham and Covington Advise on Novartis’s Acquisition of Regulus
Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800...
The Crook, the Tycoon, the Short Seller, and Trump
FOIAengine Tracks the High Cost of Getting Even, and the Rewards
Until six weeks ago, Jason Galanis was Inmate 80739-198...
Pharma Knock-Offs, a Secret Email Address, and a Smooth Spin of the Revolving Door
The Latest Requests Logged in FOIAengine
Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s...
